{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T14:56:20Z","timestamp":1743000980672,"version":"3.40.3"},"publisher-location":"Cham","reference-count":21,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030190583"},{"type":"electronic","value":"9783030190590"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/5584_2019_341","type":"book-chapter","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T22:24:39Z","timestamp":1550010279000},"page":"63-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systemic Sclerosis and Serum Content of Transforming Growth Factor"],"prefix":"10.1007","author":[{"given":"Dominik","family":"Majewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna A.","family":"Majewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kuznar-Kaminska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Runowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Piorunek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halina","family":"Batura-Gabryel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Puszczewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"341_CR1","first-page":"S5","volume":"21","author":"A Akesson","year":"2003","unstructured":"Akesson A, Fiori G, Krieg T, van den Hoogen FHJ, Seibold JR (2003) Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 21:S5\u2013S8","journal-title":"Clin Exp Rheumatol"},{"key":"341_CR2","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286\u20131292","journal-title":"N Engl J Med"},{"key":"341_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI115821","volume":"90","author":"WA Border","year":"1992","unstructured":"Border WA, Ruoslahti E (1992) Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest 90:1\u20137","journal-title":"J Clin Invest"},{"key":"341_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/berh.1999.0074","volume":"14","author":"PJ Clements","year":"2000","unstructured":"Clements PJ (2000) Systemic sclerosis (scleroderma) and related disorders: clinical aspects. Baillieres Best Pract Res Clin Rheumatol 14:1\u201316","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"341_CR5","volume-title":"Rheumatology secrets","author":"D Collier","year":"2002","unstructured":"Collier D (2002) Systemic sclerosis. In: West S (ed) Rheumatology secrets, 2nd edn. Hanley & Belfus, Philadelphia","edition":"2"},{"issue":"Suppl 5","key":"341_CR6","doi-asserted-by":"publisher","first-page":"v45","DOI":"10.1093\/rheumatology\/kex199","volume":"56","author":"M Cutolo","year":"2017","unstructured":"Cutolo M, Smith V, Furst DE, Khanna D, Herrick AL (2017) Points to consider-Raynaud\u2019s phenomenon in systemic sclerosis. Rheumatology (Oxford) 56(Suppl 5):v45\u2013v48","journal-title":"Rheumatology (Oxford)"},{"key":"341_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6064830","volume":"2016","author":"AT Dantas","year":"2016","unstructured":"Dantas AT, Gon\u00e7alves SM, de Almeida AR, Gon\u00e7alves RS, Sampaio MC, Vilar KM, Pereira MC, R\u00eago MJ, Pitta ID, Marques CD, Duarte AL, Pitta MG (2016) Reassessing the role of the active TGF-\u03b21 as a biomarker in systemic sclerosis: association of serum levels with clinical manifestations. Dis Markers 2016:6064830","journal-title":"Dis Markers"},{"key":"341_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.berh.2004.03.001","volume":"18","author":"CP Denton","year":"2004","unstructured":"Denton CP, Black CM (2004) Scleroderma \u2013 clinical and pathological advances. Best Pract Res Clin Rheumatol 18:271\u2013290","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"341_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-981-10-6020-5_6","volume":"1026","author":"J Du","year":"2017","unstructured":"Du J, Yu Y, Zhan J, Zhang H (2017) Targeted therapies against growth factor signaling in breast cancer. Adv Exp Med Biol 1026:125\u2013146","journal-title":"Adv Exp Med Biol"},{"key":"341_CR10","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1093\/rheumatology\/kei088","volume":"44","author":"M Dziadzio","year":"2005","unstructured":"Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP (2005) Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score. Rheumatology (Oxford) 44:1518\u20131524","journal-title":"Rheumatology (Oxford)"},{"key":"341_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/5584_2015_115","volume":"852","author":"K Jakubowska","year":"2015","unstructured":"Jakubowska K, Naumnik W, Nikli\u0144ska W, Chyczewska E (2015) Clinical significance of HMGB-1 and TGF-\u03b2 level in serum and BALF of advanced non-small cell lung cancer. Adv Exp Med Biol 852:49\u201358","journal-title":"Adv Exp Med Biol"},{"key":"341_CR12","volume-title":"Rheumatology","author":"JH Klippel","year":"1998","unstructured":"Klippel JH, Dieppe PA (1998) Rheumatology, 2nd edn. Mosby, London","edition":"2"},{"key":"341_CR13","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","volume":"10","author":"R Lafyatis","year":"2014","unstructured":"Lafyatis R (2014) Transforming growth factor \u03b2 \u2013 at the centre of systemic sclerosis. Nat Rev Rheumatol 10:706\u2013719","journal-title":"Nat Rev Rheumatol"},{"key":"341_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/ar1976","volume":"8","author":"A Leask","year":"2006","unstructured":"Leask A (2006) Scar wars: is TGFbeta the phantom menace in scleroderma? Arthritis Res Ther 8:213\u2013219","journal-title":"Arthritis Res Ther"},{"key":"341_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-94-007-4546-9_20","volume":"755","author":"T Piorunek","year":"2013","unstructured":"Piorunek T, Kuznar-Kaminska B, Cofta S, Batura-Gabryel H, Poplawski D, Majewski D, Puszczewicz M, Wysocka E (2013) Lung impairment in scleroderma. Adv Exp Med Biol 755:149\u2013154","journal-title":"Adv Exp Med Biol"},{"key":"341_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/5584_2014_106","volume":"852","author":"WJ Piotrowski","year":"2015","unstructured":"Piotrowski WJ, Kisza\u0142kiewicz J, Pastuszak-Lewandoska D, Antczak A, G\u00f3rski P, Migdalska-S\u0119k M, G\u00f3rski W, Czarnecka K, Nawrot E, Doma\u0144ska D, Brzezia\u0144ska-Lasota E (2015) TGF-\u03b2 and Smads mRNA expression in pulmonary sarcoidosis. Adv Exp Med Biol 852:59\u201369","journal-title":"Adv Exp Med Biol"},{"key":"341_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","volume":"138","author":"E Scala","year":"2004","unstructured":"Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, De Pit\u00e0 O, Puddu P, Paganelli R, Russo G (2004) Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 138:540\u2013546","journal-title":"Clin Exp Immunol"},{"key":"341_CR18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/ard.53.11.763","volume":"53","author":"N Snowden","year":"1994","unstructured":"Snowden N, Coupes B, Herrick A, Illingworth K, Jayson MI, Brenchley PE (1994) Plasma TGF beta in systemic sclerosis: a cross-sectional study. Ann Rheum Dis 53:763\u2013767","journal-title":"Ann Rheum Dis"},{"key":"341_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.autrev.2006.06.001","volume":"5","author":"F Verrecchia","year":"2006","unstructured":"Verrecchia F, Mauviel A, Farge D (2006) Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis. Autoimmun Rev 5:563\u2013569","journal-title":"Autoimmun Rev"},{"key":"341_CR20","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1172\/JCI114932","volume":"86","author":"LM Wakefield","year":"1990","unstructured":"Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB (1990) Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 86:1976\u20131984","journal-title":"J Clin Invest"},{"key":"341_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196559","volume":"13","author":"PJ Wermuth","year":"2018","unstructured":"Wermuth PJ, Jimenez SA (2018) Abrogation of transforming growth factor-\u03b2-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib). PLoS One 13:e0196559","journal-title":"PLoS One"}],"container-title":["Advances in Experimental Medicine and Biology","Medical Science and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2019_341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T01:07:20Z","timestamp":1561165640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2019_341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030190583","9783030190590"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/5584_2019_341","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"14 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}